within Pharmacolibrary.Drugs.ATC.R;

model R05DA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.00036666666666666667,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R05DA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ethylmorphine is an opioid analgesic and antitussive drug historically used mainly for the treatment of cough and mild to moderate pain. It is structurally related to codeine and exhibits similar pharmacological effects. Nowadays, its use is largely discontinued or highly restricted in many countries due to safety concerns regarding opioid use and potential for abuse.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Aasmundstad, TA, et al., &amp; Mørland, J (1995). Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose. <i>British journal of clinical pharmacology</i> 39(6) 611–620. DOI:<a href=\"https://doi.org/10.1111/j.1365-2125.1995.tb05720.x\">10.1111/j.1365-2125.1995.tb05720.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7654478/\">https://pubmed.ncbi.nlm.nih.gov/7654478</a></p></li><li><p>Ripel, A, et al., &amp; Mørland, J (1992). Morphine formation after intake of ethylmorphine. <i>Pharmacology &amp; toxicology</i> 70(3) 228–229. DOI:<a href=\"https://doi.org/10.1111/j.1600-0773.1992.tb00462.x\">10.1111/j.1600-0773.1992.tb00462.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1579549/\">https://pubmed.ncbi.nlm.nih.gov/1579549</a></p></li><li><p>Hedenmalm, K, et al., &amp; Dahlqvist, R (1997). Urinary excretion of codeine, ethylmorphine, and their metabolites: relation to the CYP2D6 activity. <i>Therapeutic drug monitoring</i> 19(6) 643–649. DOI:<a href=\"https://doi.org/10.1097/00007691-199712000-00007\">10.1097/00007691-199712000-00007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/9421105/\">https://pubmed.ncbi.nlm.nih.gov/9421105</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R05DA01;
